Lionheart Health Partners with CoreViva to Integrate AI-Enhanced MRI Scans into Klotho Wellness Program

Lionheart Health, Inc. has announced a strategic partnership with CoreViva to provide AI-enhanced full body MRI scans to participants in its Lionheart Klotho Wellness Program. This collaboration comes as Lionheart Health advances as a semi-finalist in the $101 million Xprize Healthspan competition, where it is testing a protocol designed to elevate circulating klotho levels through a comprehensive approach including klotho-promoting meals, daily supplements, and bioelectric klotho-enhanced exercise. The integration of CoreViva's FDA-cleared AI technology will serve as a critical baseline measurement for patients entering the program, with follow-up scans scheduled at 12 months to track progress.

Dr. Leslie Miller, Chief Medical Officer for Lionheart Health, emphasized the importance of this technology in the program's research objectives. The AI-enhanced MRI scans will provide measurable data points for tracking improvements across multiple health domains that are central to the company's healthspan research. This objective measurement capability represents a significant advancement in how longevity interventions can be validated and tracked over time.

CoreViva's mission to improve early disease detection through advanced imaging technology https://coreviva.com aligns with Lionheart Health's focus on healthspan longevity. The partnership combines cutting-edge imaging with targeted therapeutic interventions that address multiple aspects of health and wellness. Participants in the program have access to various optional therapies designed to support overall health improvement and longevity goals.

The collaboration marks an important step in validating klotho-based interventions through objective, AI-powered medical imaging. By establishing baseline measurements and tracking changes over time, the partnership creates a framework for evidence-based assessment of healthspan improvements. This approach could potentially set new standards for measuring outcomes in longevity research, moving beyond subjective reports to quantifiable medical data.

The integration of advanced imaging technology with comprehensive wellness programming represents a convergence of preventive medicine approaches. As research into healthspan extension advances, partnerships like this one demonstrate how different technological and therapeutic approaches can be combined to create more robust research methodologies. The ability to track specific health metrics through AI-enhanced imaging provides researchers with valuable data for understanding the effectiveness of various interventions.

This partnership occurs at a significant moment in longevity research, with increasing attention on measurable healthspan improvements rather than just lifespan extension. The combination of klotho-focused interventions with advanced imaging technology creates a powerful tool for understanding how specific protocols affect various aspects of health. As the field of longevity medicine continues to evolve, such integrated approaches will likely become increasingly important for validating interventions and establishing evidence-based protocols.